Upload
daniel-d-ranggadwipa
View
7
Download
2
Tags:
Embed Size (px)
DESCRIPTION
FArmako
Citation preview
SpinalCord
BrainSensoryNeuron
Neuron Sensoris• INPUT dari organ sensoris ke otak dan medula spinalis
Drawing shows a somatosensory neuron
Vision, hearing, taste and smell nerves are cranial, not spinal
SpinalCord
BrainSensoryNeuron
MotorNeuron
Neuron Motoris
• OUTPUT Dari otak dan Medula Spinalis ke otot dan kelenjar
SpinalCord
BrainSensoryNeuron
MotorNeuron
Interneuron• Membawa informasi antar neuron
• Terdapat di otak & Medula spinalis
Ion concentrations
Cell Membrane in resting state
K+
Na+ Cl-K+A-
Outside of Cell
Inside of Cell
Na+ Cl-
Membran Sell Semi-Permeable
Cell Membrane at rest
Na+ Cl-K+
Na+
Cl-K+ A-
Outside of Cell
Inside of Cell
Potassium (K+) bisa menembus membran seimbangkan konsentrasi
Sodium (Na+) & Klorida (Cl-) tidak bisa menembus
Hasil tegangan dalam sel relatif lebih negatif
- 70 mv
Bagaimana neuron otak berkomunikasi ?
Where ? SynapsesHow ? Neurotransmitters
Transporter
Jenis Neurotransmiter: 1. Amine - Acetylcholine 2. Monoamines: a. Catecholamines – Norepinephrine and Dopamine
b. Indoleamines – Serotonin3. Amino Acids – Glutamate, GABA, Glycine4. Peptides – VIP and PACAP
Synapse
• Ujung axon berisi kantong NT
vesikel sinaps
SendingNeuron
SynapseAxon
Terminal
• Jenis Sinaps 1. Elektrik
2. Kemikal
Chemical v/s Electrical SynapsesElectrical Synapses
Rapid bidirectional transmission
Gap junctions
Ion current
Electrotonic transmission
Cytoplasmic continuity
Chemical SynapsesSlow unidirectional transmission
Presynaptic vesicles, active zones, postsynaptic receptors
Chemical neurotransmitters
Complex amplifying excitatory/ inhibitory signals
Synaptic cleft
Neurotransmitters• Kriteria
1. Tersedia di presynap
2. Dilepaskan bila presynap depolarisasi dan bersifat Ca2+-dependent
3. Reseptor Specific terdapat di postsynap
Beda Neurotransmitter dengan Hormon?
Neurotransmitter HormoneProximity of action
* released adjacent to target cell
* travels 20-30 nanometers
Effects are transient
Distant action
* carried through blood
* travel nanometers to meters
Long-lasting effects
• Similarities both packed into vesicles, both expelled through cells by exocytosis, both bind to specific receptors, both depolarize target membrane
Excitatory vs Inhibitory Synapses• Type I
•Excitatory•Glutamatergic•Contact dendritic spines•Large active zone
• Type II•Inhibitory•GABA-ergic•Contact cell bodies•Small active zones
Glutamate• Principle excitatory neurotransmitter in CNS• Too much glutamate excitotoxicity
– Excessive Ca2+ entry through receptors– Stroke, degenerative disease
• Two types of glutamate receptors:1. Ionotropic
2. Metabotropic
• Involved in learning & memory
GABA• Major inhibitory neurotransmitter in CNS
– Hyperpolarizes postsynaptic membrane
• Two types of GABA Receptors:– GABA-A
• Cl- channel binding Cl- conductance in presynaptic neurons
• “fast” response (1msec)• Benzodiazepines, barbiturates
– GABA-B• G-protein coupled receptor• K+ conductance• “slow” response (1sec)
Dopamine• A Nigrostrial pathway
– Controls movement
• B Mesolimbic pathway
- “pleasure pathway”
• C Mesocortical pathway
- Learning & memory
- Interacts with mesolimbic pathway to mediate euphoric effects of drugs of abuse
• D Tuberoinfundibular pathway
- Controls release of prolactin
Serotonin Receptors• 5-HT1A CNS: neuronal inhibition, behavioral effects (sleep, feeding,
thermoregulation, anxiety)
• 5-HT1B CNS: presynaptic inhibition, behavioral effects; vascular: pulmonary vasoconstriction ergotamine
• 5-HT1D CNS: locomotion; vascular: cerebral vasoconstriction
• 5-HT2A CNS: neuronal excitation, behavioral effects; smooth muscle: contraction, vasoconstriction / dilatation; platelets: aggregation α-methyl-5-HT
• 5-HT2B stomach: contraction α-methyl-5-HT
• 5-HT2C CNS, choroid plexus: (CSF) secretion α-methyl-5-HT, LSD
• 5-HT3 CNS, PNS: neuronal excitation, anxiety, emesis
• 5-HT4 GIT, CNS: neuronal excitation, gastrointestinal motility
• 5-Ht5 CNS: unknown
• 5-Ht6 CNS: unknown
• 5-HT7 CNS, GIT, blood vessels: unknown
Glycine• Inhibitory neurotransmitter
– makes the post-synaptic membrane more permeable to Cl- hyperpolarizes the membrane
– glycine receptor is primarily found in the ventral spinal cord
• Strychnine
• glycine antagonist which can bind to the receptor without opening the Cl-channel
• (i.e. it inhibits inhibition)
• spinal hyperexcitability
Obat Neurofarmakologis
2 Kategori
• Obat Susunan Saraf Tepi
(Peripheral nervous system drugs)
• Obat Susunan Saraf Pusat
(Central nervous system drugs)
Mekanisme Dasar Obat Neuropharmacologis
1. Menyerupai kerja normal neurotransmitters2. Hambat / Block kerja normal zat kimia tubuh3. Modifikasi kerja sistem tubuh:
• Skeletal muscles• Cardiac muscle and output of blood• Vascular tone• Respiration• Gastric function• Uterine motility• Glandular secretion• CNS functions (heat, pain, mood, etc…)
• Neuron Function:– Neuron, synapse, response organ
• Reflex arc:– Sensory neuron, synapse, CNS, synapse, motor neuron
• Response through brain:– Sensory neuron, synapse, CNS spinal ganglia, brain,
spinal ganglia, motor neuron
Mekanisme Dasar Obat Neuropharmacologis
How Neuron Regulate Physiologic Processes
• 3 major steps in neuron action:1. Conduction of action potential
2. Release of neurotransmitter from axon
3. Binding of transmitter molecules to receptors on post-synaptic cell
Receptors could be:
Neuron
Muscle
Glandular cell
• Most neuropharmacologic agents act at synapse transmission level
• Axonal conduction NOT a common site of action
– (local anesthetics decrease axonal conduction)
• Synaptic transmission site more selective– (drugs elicit selective response)
Synaptic TransmissionFive steps in synaptic transmission are1. Synthesis of transmitter molecules2. Storage of transmitter molecules in the
vesicles3. Release of transmitter molecules by action
potential into synaptic gap4. Receptor binding (reversible)5. Termination by release of transmitter from
receptor and synaptic gap (by reuptake, enzymatic degradation, and diffusion)
Effects of Drugs
Drugs can
1. Enhance receptor activation• May increase effect by increasing release
– NE increases heart rate when receptors are activated
• May activate receptor BUT decrease activity– Actylcholine decreases heart rate when receptors are
activated
• Increase number of receptor molecules
2. Reduce receptor activation• Decrease response by decreasing release• Down-regulating receptor number
Effects of Drugs
1. Transmitter synthesis• Increase• Decrease• Cause synthesis of transmitter type that is more
effective than natural transmitter (higher affinity for receptor)
2. Interference with transmitter storage• Can increase storage or decrease storage in vesicles
Effects of Drugs3. Transmitter release
Promote or inhibit release– Amphetamines (CNS stimulant) increase transmitter
release– Botulinus toxin inhibits transmitter release
4. Receptor binding• Enhancement of binding (agonists)- synergism of
action- both bind to receptor• Blocking binding (antagonists)- blockage of
receptor or lowering of affinity of receptor for transmitter
4. Receptor Binding (contd…)
Neuropharmacologic drugs that act directly to the receptors can bind and• Cause activation (agonist)
– Morphine (CNS), epinephrin (cardiovasuclar system), insulin (diabetes)
• Prevent activation (antagonist)– Naloxone (overdose of morphine), antihistamine
(allergic disorder), promanol ( hypertension, angina, dysrythmiasis)
• Enhance activation (of natural transmitter) (no specific term)
– Diazepam (anxiety, seizure, muscle spasm)
Effects of Drugs
5. Termination of transmitter action– Blockade of transmitter reuptake
• increase concentration of transmitter
– Inhibition of transmitter degradation• Increase concentration of transmitter
Step in synaptic transmission
Drug action Impact on receptor activation
Synthesis of transmitter
Increased
Decreased
Synthesis of super transmitter
Increase
Decrease
Increase
Storage of transmitters Increased storage
Reduced storage
Increase
Decrease
Release of transmitters Promotion
Inhibition
Increase
Decrease
Binding to receptors Direct receptor stimulation
Mimic
Block
Increase
Increase
Decrease
Termination of transmitters
Blockade of reuptake
Prevention of breakdown
Increase
Increase